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LETTERS TO THE EDITOR
6. To¨rnig J, Amann K, Ritz E, Nichols C, Zeier M, Mall G: Arterio-High blood pressure and lar wall thickening, capillary rarefaction and interstitial fibrosis in the
heart of rats with renal failure: the effects of ramipril, nifedipine and
moxonidine. J Am Soc Nephrol 7:667–675, 1996the kidney 7. To¨rnig J, Gross M-L, Simonaviciene A, Mall G, Ritz T, Amann
K: Hypertrophy of intramyocardial arteriolar smooth muscle cells in
experimental renal failure. J Am Soc Nephrol 10:77–83, 1999
To the Editor: Once again we are indebted to Stewart
Cameron’s and Jackie Hicks’ scholarship for an entertain- Survival of hemodialysis
ing and highly informative account of the life, times and
medical contributions of Dr. William Senhouse Kirkes [1]. patients
However, I would like to point out that Bright’s original
To the Editor: I read with interest the article by Chertowhypothesis [2], as re-stated by Kirkes [3], is at the least
et al [1]. The analysis regarding vintage and nutritionalpartly correct, namely that constituents of uremic blood
status is pertinent, but the data presented regarding sur-were responsible for left ventricular hypertrophy, and in-
vival of these patients are rather inadequate. We are notdeed, aortic wall thickening. Clearly there is a major pres-
told about other common comorbid factors that affectsure contribution to uremic LVH [4], but the elegant stud-
survival in hemodialysis patients besides diabetes, likeies by Amann and colleagues in Germany also document,
coronary artery disease and chronic infections due to hep-at least in rodents, pressor-independent effects of parathy-
atitis B, hepatitis C and HIV. The authors conclude thatroid hormone (PTH) and phosphate on intercardiomyo-
a year accrued on dialysis is associated with a 6% increasecyte fibrosis [5–7], of which fibrosis is a highly important
in the risk of death, all else being equal. Since the follow-feature of “uremic cardiomyopathy” (though it is also
up period of the patients was very short (2 days to 18seen with advanced pheochromocytoma).
months), it is important to know the total patient-yearsThere is no doubt that Bright, Kirkes, Traube and Mo-
of the group. Also, the total mortality in the cohort duringhamed collectively had an astonishing insight into the
follow-up has not been mentioned.pathophysiology of raised blood pressure long before the
more comfortable modern age of being able to measure
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deed, vintage may be a proxy for comorbidity, as persons5. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role for parathy-
roid hormone for the activation of cardiac fibroblasts in uremia. J Am “accumulate” additional conditions during their years on
Soc Nephrol 4:1814–1819, 1994 dialysis. Moreover, comorbid conditions may not explain
the association between poorer nutritional status and
longer vintage, which was observed despite selection ef-
fects. Finally, we were remiss in omitting the overall mor-Ó 2000 by the International Society of Nephrology
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